Roemmers
Roemmers, officially known as Laboratorios Roemmers, is a prominent pharmaceutical company headquartered in Argentina. Established in 1921, Roemmers has grown to become a key player in the Latin American pharmaceutical industry, with a strong presence in various operational regions across the continent. Specialising in the development, manufacturing, and marketing of prescription medications, Roemmers is recognised for its commitment to quality and innovation. The company offers a diverse portfolio of products, including generics and branded pharmaceuticals, which are distinguished by their efficacy and safety. With decades of experience, Roemmers has achieved significant milestones, positioning itself as a trusted name in healthcare. Its dedication to research and development has led to numerous accolades, solidifying its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Roemmers's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roemmers's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roemmers's reported carbon emissions
As of the latest available data, Roemmers has not disclosed specific carbon emissions figures, indicating a lack of recent emissions data. The company is a current subsidiary of Laboratorios Roemmers S.A.I.C.F., which may influence its climate commitments and reporting practices. Currently, Roemmers does not have documented reduction targets or initiatives, including those aligned with the Science Based Targets initiative (SBTi). This absence of specific targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of the pharmaceutical industry, where sustainability and emissions reduction are increasingly critical, Roemmers may need to establish clear climate commitments to align with industry standards and expectations. The lack of emissions data and reduction initiatives highlights an opportunity for Roemmers to enhance its environmental accountability and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roemmers is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
